← ANALYST RATINGS · TIPRANKS
Albemarle (ALB): analyst forecast and price target
Analyst consensus
Moderate Buy6 Buy3 Hold0 Sell
Ratings of 9 analysts in the last 3 months · top analysts only12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $158, the highest $225, the lowest $109. The average is +65.2% from the last price of $95.48.
Analyst ratings 24
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Chemicals - SpecialtyxAI Grok-4 | TipRanks - xAI | $103 → $100−2.9% | Hold | +4.7% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI DeepSeek Chemicals - SpecialtyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $106 → $103−2.8% | Hold | +7.9% | Downgrade | 17.10.26on TipRanks 13:05 | — | |
| AI OpenAI Chemicals - SpecialtyOpenAI 5.2 | TipRanks - OpenAI | $101 → $98.00−3.0% | Hold | +2.6% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI Anthropic Chemicals - SpecialtyAnthropic Opus-4.6 | TipRanks - Anthropic | $99.00 → $96.00−3.0% | Hold | +0.5% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI Google Chemicals - SpecialtyGemini 3.1Pro | TipRanks - Google | $107 → $104−2.8% | Hold | +8.9% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI PerPlexity Chemicals - SpecialtyPerPlexity SonarPro | TipRanks - PerPlexity | $103 → $100−2.9% | Hold | +4.7% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| Arun Viswanathan★★★★★★★★★★#4725 · hits 54% · avg +1.5% | RBC Capital | $157 → $129−17.8% | Buy | +35.1% | Reiterated | 15.10.26on TipRanks 09:30 | −0.1%next day −1.6% | ↗ |
| John Roberts CFA★★★★★★★★★★#651 · hits 62% · avg +10.3% | Mizuho Securities | $130 | Buy | +36.2% | Upgrade | 13.10.26on TipRanks 17:55 | +1.4%next day −0.1% | ↗ |
| Unknown Analyst | Barclays | $109 | Hold | +14.2% | Initiated | 12.10.26on TipRanks Oct 13 17:55 | −2.7%next day −0.9% | ↗ |
| Vincent Andrews★★★★★★★★★★#3768 · hits 62% · avg +2.7% | Morgan Stanley | $161 | Hold | +68.6% | Reiterated | 07.10.26on TipRanks 06:16 | −3.1%next day −0.2% · 5 days −3.7% | ↗ |
| Bill Selesky★★★★★★★★★★#1503 · hits 60% · avg +7.8% | Argus Research | $230 → $135−41.3% | Buy | +41.4% | Reiterated | 06.10.26on TipRanks Oct 7 08:10 | +1.3%next day −3.1% · 5 days −8.0% | ↗ |
| Joel Jackson★★★★★★★★★★#1004 · hits 59% · avg +10.5% | BMO Capital | $200 → $175−12.5% | Buy | +83.3% | Reiterated | 06.10.26on TipRanks 08:01 | +1.3%next day −3.1% · 5 days −8.0% | ↗ |
| Joshua Spector★★★★★★★★★★#3207 · hits 53% · avg +3.3% | UBS | $175 → $150−14.3% | Buy | +57.1% | Reiterated | 05.10.26on TipRanks 05:55 | −0.9%next day +1.3% · 5 days −6.0% | ↗ |
| Laurence Alexander★★★★★★★★★★#5965 · hits 50% · avg +0.8% | Jefferies | $211 | Buy | +121.0% | Reiterated | 11.09.26on TipRanks 10:26 | −4.3%next day −1.7% · 5 days −5.5% | ↗ |
| Jeffrey Zekauskas★★★★★★★★★★#2991 · hits 53% · avg +3.3% | J.P. Morgan | $160 → $140−12.5% | Hold | +46.6% | Assigned | 25.08.26on TipRanks 08:10 | −6.2%next day +1.0% · 5 days +2.3% | ↗ |
| Tina Ting Hu★★★★★★★★★★#2594 · hits 45% · avg +25.8% | DBS | $170 | Buy | +78.0% | Reiterated | 20.08.26on TipRanks Aug 24 03:35 | +0.8%next day +6.3% · 5 days +0.1% | ↗ |
| Pete Osterland★★★★★★★★★★#1396 · hits 60% · avg +19.4% | Truist Financial | $225 | Buy | +135.7% | Reiterated | 11.08.26on TipRanks Aug 12 22:25 | −1.1%next day −1.0% · 5 days +3.0% | ↗ |
| Ben Isaacson★★★★★★★★★★#2733 · hits 49% · avg +6.0% | Scotiabank | $200 → $190−5.0% | Buy | +99.0% | Reiterated | 10.08.26on TipRanks 07:45 | +0.1%next day −1.1% · 5 days +2.2% | ↗ |
| Eric Boyes★★★★★★★★★★#5799 · hits 57% · avg +3.2% | Evercore ISI | $180 | Hold | +88.5% | Reiterated | 07.08.26on TipRanks 13:07 | +3.9%next day +0.1% · 5 days +3.4% | ↗ |
| Patrick Cunningham★★★★★★★★★★#4783 · hits 54% · avg +2.3% | Citi | $225 → $175−22.2% | Buy | +83.3% | Reiterated | 07.08.26on TipRanks 07:01 | +3.9%next day +0.1% · 5 days +3.4% | ↗ |
| Matthew DeYoe★★★★★★★★★★#2749 · hits 62% · avg +7.2% | Bank of America Securities | $155 | Buy | +62.3% | Reiterated | 07.08.26on TipRanks 04:50 | +3.9%next day +0.1% · 5 days +3.4% | ↗ |
| Michael Sison★★★★★★★★★★#11471 · hits 43% · avg −2.5% | Wells Fargo | $200 | Hold | +109.5% | Reiterated | 04.06.26on TipRanks Jun 5 05:40 | −2.0%next day −3.6% · 5 days −1.4% | ↗ |
| Andres Castanos-Mollor★★★★★★★★★★#10808 · hits 39% · avg −3.9% | Berenberg Bank | $153 → $192+25.5% | Hold | +101.1% | Reiterated | 02.06.26on TipRanks Jun 3 01:30 | +0.2%next day −1.3% · 5 days −8.1% | ↗ |
| Kevin McCarthy★★★★★★★★★★#3631 · hits 61% · avg +7.5% | Vertical Research | $224 | Buy | +134.6% | Upgrade | 26.05.26on TipRanks 07:11 | +1.1%next day +1.6% · 5 days −2.9% | ↗ |
| David Begleiter★★★★★★★★★★#4870 · hits 52% · avg +1.4% | Deutsche Bank | $210 → $250+19.0% | Buy | +161.8% | Reiterated | 12.05.26on TipRanks 21:20 | −2.8%next day −5.7% · 5 days −15.1% | ↗ |
| Ben Kallo★★★★★★★★★★#2316 · hits 43% · avg +6.2% | Robert W. Baird | $210 → $236+12.4% | Hold | +147.2% | Reiterated | 08.05.26on TipRanks 09:00 | +1.8%next day +3.0% · 5 days −11.6% | ↗ |
| Mazahir Mammadli★★★★★★★★★★#9219 · hits 33% · avg −2.8% | Rothschild & Co Redburn | $185 → $188+1.6% | Hold | +96.9% | Downgrade | 22.04.26on TipRanks 04:50 | −3.1%next day −0.2% · 5 days −1.8% | ↗ |
| Ishan Jain★★★★★★★★★★#10729 · hits 0% · avg −31.0% | HSBC | $200 | Buy | +109.5% | Upgrade | 18.01.26on TipRanks Jan 19 14:40 | +7.9%next day +3.2% · 5 days +9.9% | ↗ |
| Aleksey Yefremov★★★★★★★★★★#1445 · hits 57% · avg +7.5% | KeyBanc | — | Hold | — | Reiterated | 07.11.25on TipRanks 07:40 | +6.4%next day +5.0% · 5 days +18.3% | ↗ |
| David Deckelbaum★★★★★★★★★★#1693 · hits 49% · avg +10.0% | TD Cowen | $85.00 | Hold | −11.0% | Reiterated | 05.11.25on TipRanks 23:10 | +0.3%next day +6.4% · 5 days +25.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Albemarle
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $175 at a price of $106 (+65.0%); now: $162 at $95.48 (+70.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 5 | 5 | 4 |
| Buy | 9 | 8 | 6 | 3 | 3 | 4 |
| Hold | 6 | 7 | 6 | 7 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.58 (from $1.81 to $3.40). Last quarter: $3.75.
Sales
Next quarter’s sales estimate — $1.5B (from $1.4B to $1.7B). Last quarter: $1.7B.
Best top-analyst consensus in the sector · Basicmaterials
About Albemarle
- CEO: Jerry Kent Jr.
- Employees: 7,800
- 4250 Congress Street, Charlotte, NC, 28209, US
- www.albemarle.com
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Establis
Data from the stock’s TipRanks forecast page, read 5 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗